Ingrid McPhilliamy

Ingrid McPhilliamy is an experienced professional in the pharmaceutical and healthcare industries, currently serving as the Global Product Development & Commercialization Lead for SPINRAZA at Biogen, where Ingrid has also held the position of Executive Director for Global Commercial Lead, SPINRAZA. Prior experience includes roles as Vice President of Marketing for the Gout Business Unit and Executive Director of Rheumatology Marketing at Horizon. Additionally, Ingrid has held senior management positions at Fresenius Kabi USA, Fenwal, Inc., and Baxter International Inc., with responsibilities ranging from strategy and business development to therapeutic apheresis and cell therapy marketing. Ingrid holds an MBA in Marketing from Northwestern University - Kellogg School of Management and a Baccalaureate in Industrial Design from The University of Kansas.